Expertise in
9
conditions

Lucas V. Boersma

St. Antonius Ziekenhuis
Nieuwegein, UT, NL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
St. Antonius Ziekenhuis
Nieuwegein, UT, NL 
OverviewLocationsClinical Research

Overview

Lucas Boersma practices in Nieuwegein, Netherlands. Mr. Boersma is highly rated in 9 conditions, according to our data. His top areas of expertise are Atrial Fibrillation, Ventricular Fibrillation, Ventricular Tachycardia, Cardiac Ablation, and Mastectomy.

His clinical research consists of co-authoring 229 peer reviewed articles and participating in 19 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St. Antonius Ziekenhuis
Nieuwegein, UT, Netherlands
Other Locations
St. Jans Gasthuis
Weert, LI, Netherlands
Erasmus MC
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Enrollment Status: Completed
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
Enrollment Status: Completed
Publish Date: February 13, 2025
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies
Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
iCLAS™ for Persistent Atrial Fibrillation
iCLAS™ for Persistent Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
Cryoablation for Monomorphic Ventricular Tachycardia
Cryoablation for Monomorphic Ventricular Tachycardia
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2024
Intervention Type: Device
Study Phase: Not Applicable
AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)
AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)
Enrollment Status: Terminated
Publish Date: November 13, 2023
Intervention Type: Device
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Enrollment Status: Terminated
Publish Date: June 08, 2023
Intervention Type: Device
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Enrollment Status: Unknown
Publish Date: May 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Device
Study Phase: Not Applicable
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Device
A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter
A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter
Enrollment Status: Completed
Publish Date: May 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 18 Less Clinical Trials

229 Total Publications

THE BLANKING PERIOD AFTER ABLATION OF ATRIAL FIBRILLATION: LESSONS LEARNED IN 2024-2025.
THE BLANKING PERIOD AFTER ABLATION OF ATRIAL FIBRILLATION: LESSONS LEARNED IN 2024-2025.
Journal: Heart rhythm
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Boersma's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile